← Back
Data updated: Mar 29, 2026
ASCENT PHARMS INC
OncologyMetabolic
Generics
ASCENT PHARMS INC is a generic drug manufacturer focused on Oncology, Metabolic.
2015
Since
38
Drugs
-
Trials
975
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 67%
2 drugs
Metabolic 33%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (23)
RIVAROXABAN LISDEXAMFETAMINE DIMESYLATE LUBIPROSTONE ICOSAPENT ETHYL MIRABEGRON SODIUM OXYBATE PALIPERIDONE BEXAROTENE OMEGA-3-ACID ETHYL ESTERS BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE MELOXICAM TOPIRAMATE LEVOTHYROXINE SODIUM FAMOTIDINE HYDROMORPHONE HYDROCHLORIDE POTASSIUM CITRATE IBUPROFEN METHYLPHENIDATE HYDROCHLORIDE METHADONE HYDROCHLORIDE
Discontinued (15)
GABAPENTIN OXYCODONE AND ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN OXYCODONE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE POTASSIUM CHLORIDE ESCITALOPRAM OXALATE DUTASTERIDE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE IBUPROFEN AND FAMOTIDINE DEXMETHYLPHENIDATE HYDROCHLORIDE CARBIDOPA AND LEVODOPA GEMFIBROZIL DRONABINOL BENZONATATE
Company Info
- First Approval
- 2015-09-22
- Latest
- 2026-01-21
- Applications
- 53